Inhibition of hippocampal interleukin-6 receptor-evoked signalling normalises long-term potentiation in dystrophin-deficient mdx mice
Duchenne muscular dystrophy (DMD), an X-linked neuromuscular disorder, characterised by progressive immobility, chronic inflammation and premature death, is caused by the loss of the mechano-transducing signalling molecule, dystrophin. In non-contracting cells, such as neurons, dystrophin is likely...
Saved in:
Main Authors: | Kimberley A. Stephenson, Aaron Barron, Mark G. Rae, Dervla O'Malley |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Brain, Behavior, & Immunity - Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666354624002138 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Titin fragment is a sensitive biomarker in Duchenne muscular dystrophy model mice carrying full-length human dystrophin gene on human artificial chromosome
by: Yosuke Hiramuki, et al.
Published: (2025-01-01) -
A structural genomics approach to investigate Dystrophin mutations and their impact on the molecular pathways of Duchenne muscular dystrophy
by: Abdelbaset Mohamed Elasbali, et al.
Published: (2025-02-01) -
Beta-hydroxy-beta-methylbutyrate (HMB) improves daily activity and whole-body protein metabolism in Duchenne muscular dystrophy dogs: a pilot study
by: Peter P. Nghiem, et al.
Published: (2025-02-01) -
Regional anesthesia and muscle-wasting diseases in pediatrics: A focused educational review
by: Amr Elhamrawy, et al.
Published: (2025-01-01) -
Caregiver Global Impression Observations from EMBARK: A Phase 3 Study Evaluating Delandistrogene Moxeparvovec in Ambulatory Patients with Duchenne Muscular Dystrophy
by: Craig M. McDonald, et al.
Published: (2024-11-01)